A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Ronald H. W. Cooper net worth and biography

Ronald Cooper Biography and Net Worth

CEO of Albireo Pharma

Ron Cooper, Albireo’s first President and CEO, is a global P&L leader with a track record of growing businesses, brands and organizations in the U.S. and Europe. For over 25 years, Ron worked in five different countries and held positions of increasing responsibility in sales, marketing and general management with Bristol-Myers Squibb, culminating in his role as President of Europe where he was responsible for over 30 countries with sales exceeding $4.5 billion.

While at BMS, Ron played a leadership role in several product successes, including Abilify®, Avapro®, Atripla®, Eliquis®, Orencia®, Pravachol®, Plavix®, Reyataz®, Sustiva®, Sprycel® and Yervoy®. Ron has successfully completed more than a dozen business development deals, including the creation of the first single tablet HIV/AIDS regimen partnership. He is a graduate of St. Francis Xavier University in Canada.

What is Ronald H. W. Cooper's net worth?: The estimated net worth of Ronald H. W. Cooper is at least $2.54 million as of January 23rd, 2023. Mr. Cooper owns 57,444 shares of Albireo Pharma stock worth more than $2,536,153 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Cooper may own. Learn More about Ronald H. W. Cooper's net worth.
How do I contact Ronald H. W. Cooper?: The corporate mailing address for Mr. Cooper and other Albireo Pharma executives is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Albireo Pharma can also be reached via phone at (857) 254-5555 and via email at [email protected]. Learn More on Ronald H. W. Cooper's contact information.
Has Ronald H. W. Cooper been buying or selling shares of Albireo Pharma?: Ronald H. W. Cooper has not been actively trading shares of Albireo Pharma in the last ninety days. Most recently, Ronald Harold Wilfred Cooper sold 1,057 shares of the business's stock in a transaction on Monday, January 23rd. The shares were sold at an average price of $43.80, for a transaction totalling $46,296.60. Following the completion of the sale, the chief executive officer now directly owns 57,444 shares of the company's stock, valued at $2,516,047.20. Learn More on Ronald H. W. Cooper's trading history.
Who are Albireo Pharma's active insiders?: Albireo Pharma's insider roster includes Ronald Cooper (CEO), Jason Duncan (Insider), Simon Harford (CFO), Patrick Horn (Insider), Jan Mattsson (Insider), and Pamela Stephenson (insider). Learn More on Albireo Pharma's active insiders.

Ronald H. W. Cooper Insider Trading History at Albireo Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/23/2023	Sell	1,057	$43.80	$46,296.60	57,444
10/24/2022	Sell	919	$19.58	$17,994.02	55,461
7/22/2022	Sell	929	$24.67	$22,918.43	56,380
4/22/2022	Sell	907	$33.11	$30,030.77	56,082
1/24/2022	Sell	3,684	$24.88	$91,657.92
11/13/2018	Buy	1,026	$25.02	$25,670.52	7,760
8/14/2018	Buy	788	$31.85	$25,097.80

Ronald H. W. Cooper Buying and Selling Activity at Albireo Pharma

Albireo Pharma Company Overview

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Today's Range

Now: $44.15

$43.99

$44.90

50 Day Range

MA: $44.17

$43.50

$44.95

2 Week Range

Now: $44.15

$16.02

$45.23

Volume

1,241,200 shs

Average Volume

704,539 shs

Market Capitalization

$913.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad